Beacon Medical Interchange

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Beacon Medical Interchange

beaconmedic.com

Lung
Testicular
Prostate
Renal Cell
Bladder
Gastrointestinal
General

Playback speed

10 seconds

Has the KEYNOTE-189 Trial Defined a Clear Standard of Care in Metastatic NSCLC?

By Beacon Medical Interchange FEATURING Jack West

0 views

November 2, 2018

Dr. Jack West reviews the results and pending questions of the KEYNOTE-189 trial of chemotherapy ...
read more ↘ with or without pembrolizumab (KEYTRUDA) as first line therapy for advanced non-squamous NSCLC, as well as how they change the treatment landscape.
↖ read less

Comments 0